Results 71 to 80 of about 7,633 (200)

Outcomes and Reclassification Patterns in Inflammatory Bowel Disease Unclassified: A Multicenter Study Matched With Ulcerative Colitis From Spanish ENEIDA Registry

open access: yesJournal of Gastroenterology and Hepatology, Volume 41, Issue 11, Page 3413-3421, November 2026.
ABSTRACT Background and Aim Around 10% of patients with inflammatory bowel disease do not fulfill the diagnostic criteria for Crohn's disease (CD) or ulcerative colitis (UC). These cases are labelled as inflammatory bowel disease unclassified (IBDU).
M. González‐Vivó   +23 more
wiley   +1 more source

Simple and sensitive spectrophotometric methods for the analysis of mesalamine in bulk and tablet dosage forms

open access: yesQuímica Nova, 2011
Three simple, sensitive, economical and reproducible spectrophotometric methods (A, B and C) are described for determination of mesalamine in pure drug as well as in tablet dosage forms. Method A is based on the reduction of tungstate and/or molybdate in
Bala Sekaran Chandra   +5 more
doaj   +1 more source

Differential diagnosis problem of pulmonary changes in ulcerative colitis [PDF]

open access: yesVojnosanitetski Pregled, 2010
Introduction. Inflammatory intestinal diseases are often accompanied with extraintestinal and even pulmonary manifestations. The treatment of these intestinal diseases includes sulphasalazine and mesalazine, which may have undesirable allergic and other ...
Đurić Mirna   +3 more
doaj   +1 more source

Biological Activities, Medicinal Uses, and Nutritional Effects of Terminalia arjuna (Roxb. ex DC.) Wight & Arn.: Phytochemical Insights and Therapeutic Benefits in Ulcerative Colitis Management—A Detailed Review

open access: yesFood Science &Nutrition, Volume 14, Issue 9, September 2026.
This graphical abstract highlights the versatile therapeutic potential and food applications of Terminalia arjuna, centering on its broad health‐promoting bioactivities. Key mechanisms described include adaptogenic, cardioprotective, gastroprotective, wound‐healing, and anti‐inflammatory effects mediated through Nrf2 and NF‐κB signaling pathways ...
Rameen Naeem   +8 more
wiley   +1 more source

Enhanced Bioavailability and Targeted Delivery of Mesalamine for Crohn’s Disease Using Microemulsion Formulations [PDF]

open access: yes
This study evaluates mesalamine-loaded microemulsions designed to enhance drug bioavailability and site-specific delivery in the gastrointestinal (GI) tract, targeting the treatment of Crohn\u27s disease.
Subham Mandal   +5 more
core   +1 more source

Bronchiectasis as an Underrecognized Extraintestinal Manifestation of Inflammatory Bowel Disease

open access: yesJCC Plus, Volume 1, Issue 5, September 2026.
ABSTRACT Introduction Inflammatory bowel diseases (IBD) are chronic inflammatory diseases of the gastrointestinal tract, often presenting with extraintestinal manifestations (EIMs). The most prevalent pulmonary EIM is IBD‐associated bronchiectasis (IBD‐BE), which is often overlooked.
Lynn te Slaa   +2 more
wiley   +1 more source

Isolated Mild Hyperemia Identified by Intestinal Ultrasound Is Associated With Adverse Outcomes in Inflammatory Bowel Disease

open access: yesJCC Plus, Volume 1, Issue 5, September 2026.
ABSTRACT Background Increased bowel wall thickness (BWT) measured by intestinal ultrasound (IUS) is the most predictive sonographic parameter of endoscopic disease activity in Crohn's disease (CD) and ulcerative colitis (UC). The clinical significance of hyperemia in the absence of increased BWT has yet to be delineated.
Noa Krugliak Cleveland   +8 more
wiley   +1 more source

Management of Refractory and Difficult‐To‐Treat Inflammatory Bowel Disease: An Expert Opinion Review

open access: yesJCC Plus, Volume 1, Issue 5, September 2026.
This expert opinion offers a practical framework for refractory and difficult‐to‐treat IBD: confirm inflammation objectively, distinguish pharmacologic from structural and functional disease, and then escalate. Across ten clinical questions, the evidence is often limited to case series, and the resulting statements are identified as expert opinion ...
Filiz Akyuz   +10 more
wiley   +1 more source

Effect of Intestinal Microbiota Transplantation on Intestinal Flora and Inflammatory Factor Levels in Patients with Ulcerative Colitis

open access: yesInfection and Drug Resistance, 2023
Zhi Wang,1,* Li Yang,2,* Shan Sun2 1Pediatric Gastrointestinal Surgery, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, People’s Republic of China; 2Gastroenterology, Sinopharm Dongfeng General Hospital, Hubei ...
Wang Z, Yang L, Sun S
doaj  

Viewpoint: Toward Sustainable Green Inflammatory Bowel Disease Care

open access: yesJCC Plus, Volume 1, Issue 5, September 2026.
ABSTRACT Climate change is increasingly recognized as a major determinant of human health, whereas healthcare systems themselves contribute substantially to ecosystem degradation. Inflammatory bowel disease (IBD) is a chronic disease that requires long‐term monitoring, frequent endoscopic procedures, ongoing pharmacological therapy, and potentially ...
Claire Liefferinckx   +1 more
wiley   +1 more source

Home - About - Disclaimer - Privacy